Home > Clinical Trials
Check All Search

Saved trials

RECRUITING
NCT07478991
Azacytidine, Venetoclax Plus Minus Quizartinib for First Line Older/Unfit AML Patients (VENP-A-QUI)
376 Enrollment(s)
51 Study location(s)
INTERVENTIONAL (PHASE3)
Acute Myeloid Leukemia, Adult
RECRUITING
NCT04616560
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
55 Enrollment(s)
29 Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
Desmoplastic Small Round Cell Tumor


Osteosarcoma


Recurrent Desmoplastic Small Round Cell Tumor


Recurrent Kidney Wilms Tumor


Recurrent Osteosarcoma


Refractory Desmoplastic Small Round Cell Tumor


Refractory Wilms Tumor


Wilms Tumor
RECRUITING
NCT04585958
Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer
55 Enrollment(s)
7 Study location(s)
INTERVENTIONAL (PHASE1)
Metastatic Malignant Solid Neoplasm


Platinum-Resistant Ovarian High Grade Serous Adenocarcinoma


Unresectable Malignant Solid Neoplasm
RECRUITING
NCT07548710
Study of SA+X in the Treatment of Newly Diagnosed AML
205 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Acute Myeloid Leukemia
ACTIVE_NOT_RECRUITING
NCT04784715
Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)
1,157 Enrollment(s)
283 Study location(s)
INTERVENTIONAL (PHASE3)
Breast Cancer; HER2-positive; Metastatic
NOT_YET_RECRUITING
NCT07629635
Migraine Headaches Elimination With Patent Foramen Ovale-Directed Therapy
32 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE3)
Migraine Disease


Patent Foramen Ovale
RECRUITING
NCT07022483
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
710 Enrollment(s)
75 Study location(s)
INTERVENTIONAL (PHASE3)
Endometrial Cancer
RECRUITING
NCT07124000
DESTINY-PANTUMOUR04
100 Enrollment(s)
18 Study location(s)
OBSERVATIONAL (None)
Adenocarcinoma (NOS)


Anal Cancer


Bladder Cancer


Cervical Cancer


Endometrial Cancer


Esophageal Cancer


Gall Bladder Cancer


Gastrointestinal Stromal Tumour


Head and Neck Cancer


Liver Cancer


Melanoma


Mouth Cancer


Nasopharangeal Cancer


Neuroendocrine, Gastrointestinal Cancer


Ovarian Cancer


Pancreatic Cancer


Prostate Cancer


Renal Cell Carcinoma


Salivary Gland Cancer


Sarcoma


Small Cell Lung Cancer


Testicular Cancer


Throat Cancer


Thyroid Cancer


Urethral Cancer


Vaginal Cancer


Vulvar Cancer